Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Kukje Pharma Co FCF Yield % Related Terms
Kukje Pharma Co FCF Yield % Historical Data
* Premium members only.
The historical data trend for Kukje Pharma Co's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Kukje Pharma Co's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kukje Pharma Co FCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Kukje Pharma Co's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Kukje Pharma Co's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kukje Pharma Co (XKRX:002720) has a FCF Yield % of -1.72 as of Aug. 16, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Kukje Pharma Co and its competitors. According to the industry distribution chart, Kukje Pharma Co ranks #653 out of 1003 companies in the Drug Manufacturers industry, placing it in the top 65.1%.
Is Kukje Pharma Co's FCF Yield % too high?
Kukje Pharma Co's current FCF Yield % is -1.72. Based on the distribution chart, Kukje Pharma Co ranks #653 out of 1003 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Kukje Pharma Co has a GF Score™ of 61/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Kukje Pharma Co's FCF Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Kukje Pharma Co ranks #653 out of 1003 companies for FCF Yield %. This places Kukje Pharma Co in the lower half of its industry. The industry median FCF Yield % is 0.64. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Drug Manufacturers company?
The median FCF Yield % among Drug Manufacturers companies is 0.64, based on 1,003 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Kukje Pharma Co and its competitors. For the Drug Manufacturers industry, the median FCF Yield % is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kukje Pharma Co's current FCF Yield % is -1.72. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kukje Pharma Co stock overvalued right now?
Based on GuruFocus' analysis, Kukje Pharma Co (XKRX:002720) is currently considered Possible Value Trap. The stock's GF Value™ is ₩5,952.85, compared to a current price of ₩3,355.00 — trading 43.6% below its estimated fair value. The current FCF Yield % is -1.72. Kukje Pharma Co's overall GF Score™ is 61/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Kukje Pharma Co (XKRX:002720), the current FCF Yield % is -1.72 as of Aug. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kukje Pharma Co (XKRX:002720) Overvalued in 2026?
Based on GuruFocus' analysis, Kukje Pharma Co stock appears to be undervalued.
The current stock price of ₩3,355.00 is trading 43.6% below its estimated GF Value™ of ₩5,952.85.
GuruFocus considers Kukje Pharma Co to be Possible Value Trap.
Key valuation signals for XKRX:002720:
FCF Yield %: -1.72
GF Value™: ₩5,952.85 vs. price of ₩3,355.00 (43.6% below fair value)
No single metric tells the full story. See the XKRX:002720 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kukje Pharma Co Ltd is engaged in the manufacturing and sales of pharmaceutical products, and it handles over-the-counter and prescription drugs such as Q-Allon eye drops, Letium tablets, Ezerova tablets, Colencia soft capsules, and International Cephazedon injection.
61GF Score
Get the complete analysis for XKRX:002720
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKRX:002720 has been successfully added to your 
